Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07213531) titled 'Enhanced Valves Interventions and Safe AI Generated End Results' on Sept. 24.
Study Type: Observational
Primary Sponsor: Montreal Heart Institute
Condition:
Heart Valve Disease
TAVI
M-TEER
TTVI
TMVI
T-TEER
Mitraclip
TriClip
Intervention:
Diagnostic Test: Medical imaging analysis via artificial intelligence algorithms
Recruitment Status: Recruiting
Date of First Enrollment: May 1, 2024
Target Sample Size: 21000
Countries of Recruitment:
United States
Canada
France
Germany
Italy
Canada
France
Germany
Italy
United States
To know more, visit https://clinicaltrials.gov/study/NCT07213531
Published by HT Digita...